Menu
Back to Journals » Nanotechnology, Science and Applications » Volume 9
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
Authors Masarudin MJ , Cutts S, Pietersz G, Evison B, Phillips D, Pigram P
Received 13 May 2016
Accepted for publication 13 May 2016
Published 5 August 2016 Volume 2016:9 Pages 47—48
Masarudin MJ, Cutts SM, Evison BJ et al. Nanotechnol Sci Appl. 2015;8:67–80
The authors advise that Professor Geoffrey A Pietersz was erroneously omitted from the original author and affiliation list, the list should have been:
Mas Jaffri Masarudin1
Suzanne M Cutts2
Geoffrey A Pietersz3
Benny J Evison4
Don R Phillips2
Paul J Pigram5
1Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 2Department of Biochemistry, La Trobe University, Melbourne, Victoria, Australia; 3Bioorganic and Medicinal Chemistry Laboratory, Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, Australia; 4Department of Chemical Biology and Therapeutics, St Jude Children’s Hospital, Memphis, TN, USA; 5Department of Physics, La Trobe University, Melbourne, Victoria, Australia
The Acknowledgment section should have contained the statement: This work was also supported by a research grant from Cancer Council Victoria.
Read the original article
© 2016 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.